# The Bladder Instillation Comparison Study

> **NCT02695771** · PHASE3 · COMPLETED · sponsor: **Corewell Health West** · enrollment: 101 (actual)

## Conditions studied

- Urinary Bladder Neoplasms

## Interventions

- **DRUG:** Mitomycin C
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT02695771
- **Lead sponsor:** Corewell Health West
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-19
- **Primary completion:** 2021-10-22
- **Final completion:** 2021-10-22
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2023-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02695771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02695771, "The Bladder Instillation Comparison Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02695771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*